Article

Feature Article
Abstract

Background: Personalized medicine (PM) seeks to customize diagnostics and therapeutics based on a thorough understanding of individual characteristics, including genotypic, phenotypic, and behavioral aspects. This approach strives to create timely and effective treatment and prevention measures. Advancements in technology and data-driven systems in healthcare are key to progress in enabling this personalized approach. Recent advancements are enhancing implantology by individualizing patient care and therapies. These include artificial intelligence (AI), OMICS (the full set of biological molecules in an individual), computer-assisted implant surgery (CAIS), three-dimensional (3D) printing and bioprinting.

Objectives: This narrative review explores current aspects of personalized implantology and its clinical implementation.

Conclusion: While it may be a distant reality, personalized implantology holds great potential. Once feasible, it will improve disease prediction and enable targeted prevention and therapies, ultimately enhancing patient outcomes and minimizing side effects.


Introduction

Personalized Medicine (PM) is a concept focused on customizing treatment strategies to suit each patient's unique requirements. This approach requires a thorough analysis of complex biological systems and individual phenotypic and behavioral data, incorporating both biological and clinical information. The main goal is to provide timely, effective, and safe diagnoses and treatments while implementing preventive measures tailored to a patient’s presenting condition and disease management. This comprehensive integration aims to deliver optimal preventive and therapeutic care. PM shares some elements with the P4 medicine concept, which stands for a more precise and personalized but also preventive and participatory approach towards healthcare (European Council 2015; Joda & Zitzmann 2022; Bartold & Ivanovski 2022; Schwendicke & Krois 2022) (Fig. 1).

open_in_full
Fig. 1: P4 Medicine is a holistic model that combines predictive, preventive, personalized, and participatory elements

PM began to take shape in the 1990s, driven by advancements in genomic research and data processing technologies (Colins & Fink 1995). Although there have been initial advancements such as the use of omics technology to identify disease-associated genes and therapeutic targets (Hood 2013; Pirmohamed 2023), the implementation of PM, particularly in the dental field, is still in its conceptualization and requires much development.

Dentistry is currently in an era of stratifying patients into risk groups by risk assessment. By evaluating risk factors, dental professionals can better tailor preventive measures and treatment plans to enhance patient outcomes. This approach inherently assigns the same treatment to entire groups, thereby limiting the capacity for personalized care (Schwendicke & Krois 2022; Hung et al. 2023). Understanding factors that contribute to disease pathogenesis, progression and management at an individual level is essential for personalized dentistry. This helps predict responses to etiological factors, treatment effectiveness, and the likelihood of disease development. A significant advancement in personalized care will be the identification of reliable, clinically validated biomarkers associated with specific diseases. These biomarkers can help guide therapeutic targets, reduce diagnostic errors, and monitor treatment response. Furthermore, when combined with epidemiological and outcome studies, they can support the evaluation of intervention effectiveness and allow for the adaptation of procedures to meet the unique requirements of each patient (Kornman & Duff 2012; Ballman 2015).

Implant dentistry, whether in clinical or research settings, has the potential to incorporate various technological and computational innovations, such as artificial intelligence (AI), three-dimensional (3D) printing, virtual surgical and prosthetic planning, and omics (defined as the characterization and quantification of the full set of biological molecules in an organism). These advancements show promising potential for the future implementation of personalized implantology. This article focuses on the current aspects of personalized implantology and explores its prospects.